Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Optimising the vaccine strateg...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control

Bibliographic Details
Main Authors: Wajja, A, Nassanga, B, Natukunda, A, Serubanja, J, Tumusiime, J, Akurut, H, Oduru, G, Nassuuna, J, Kabagenyi, J, Morrison, H, Scott, H, Powell Doherty, R, Marshall, JL, Cabrera Puig, I, Cose, S, Kaleebu, P, Webb, EL, Satti, I, McShane, H, Elliott, AM
Other Authors: TB042 Study Team
Format: Journal article
Language:English
Published: Elsevier 2024
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial
    by: Wajja, A, et al.
    Published: (2023)
  • The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
    by: Wajja, A, et al.
    Published: (2017)
  • The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
    by: Anne Wajja, et al.
    Published: (2017-05-01)
  • Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A
    by: Wajja, A, et al.
    Published: (2018)
  • DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
    by: Mcshane, H
    Published: (2008)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs